Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study.
Nüßlein HG, Alten R, Galeazzi M, Lorenz HM, Nurmohamed MT, Bensen WG, Burmester GR, Peter HH, Peichl P, Pavelka K, Chartier M, Poncet C, Rauch C, Le Bars M. Nüßlein HG, et al. Among authors: alten r. Clin Exp Rheumatol. 2016 May-Jun;34(3):489-99. Epub 2016 Mar 10. Clin Exp Rheumatol. 2016. PMID: 26966919
Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial.
Braun J, Brandt J, Listing J, Zink A, Alten R, Burmester G, Golder W, Gromnica-Ihle E, Kellner H, Schneider M, Sörensen H, Zeidler H, Reddig J, Sieper J. Braun J, et al. Among authors: alten r. Arthritis Rheum. 2003 Aug;48(8):2224-33. doi: 10.1002/art.11104. Arthritis Rheum. 2003. PMID: 12905476 Free article. Clinical Trial.
Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years.
Braun J, Baraliakos X, Brandt J, Listing J, Zink A, Alten R, Burmester G, Gromnica-Ihle E, Kellner H, Schneider M, Sörensen H, Zeidler H, Sieper J. Braun J, et al. Among authors: alten r. Rheumatology (Oxford). 2005 May;44(5):670-6. doi: 10.1093/rheumatology/keh584. Epub 2005 Mar 9. Rheumatology (Oxford). 2005. PMID: 15757965 Clinical Trial.
Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis.
Díaz-González F, Alten RH, Bensen WG, Brown JP, Sibley JT, Dougados M, Bombardieri S, Durez P, Ortiz P, de-Miquel G, Staab A, Sigmund R, Salin L, Leledy C, Polmar SH. Díaz-González F, et al. Among authors: alten rh. Ann Rheum Dis. 2007 May;66(5):628-32. doi: 10.1136/ard.2006.062554. Epub 2006 Dec 14. Ann Rheum Dis. 2007. PMID: 17170051 Free PMC article. Clinical Trial.
Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitis.
Baraliakos X, Listing J, Rudwaleit M, Brandt J, Alten R, Burmester G, Gromnica-Ihle E, Haibel H, Schewe S, Schneider M, Sörensen H, Zeidler H, Visvanathan S, Sieper J, Braun J. Baraliakos X, et al. Among authors: alten r. J Rheumatol. 2007 Mar;34(3):510-5. Epub 2007 Feb 1. J Rheumatol. 2007. PMID: 17299842 Clinical Trial.
[Current therapeutic strategy for rheumatoid arthritis].
Wollenhaupt J, Alten R, Burkhardt H, Edelmann E, Gromnica-Ihle E, Krause A, Krüger K, Manger B, Lorenz H, Müller-Ladner U, Nüsslein H, Pott HG, Tony H, Schneider M. Wollenhaupt J, et al. Among authors: alten r. MMW Fortschr Med. 2006 Oct 19;148(42):38-42; quiz 43. MMW Fortschr Med. 2006. PMID: 17621798 German.
Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response.
Braun J, Baraliakos X, Listing J, Fritz C, Alten R, Burmester G, Krause A, Schewe S, Schneider M, Sörensen H, Zeidler H, Sieper J. Braun J, et al. Among authors: alten r. Ann Rheum Dis. 2008 Mar;67(3):340-5. doi: 10.1136/ard.2007.075879. Epub 2007 Oct 29. Ann Rheum Dis. 2008. PMID: 17967831 Free article. Clinical Trial.
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.
Naranjo A, Sokka T, Descalzo MA, Calvo-Alén J, Hørslev-Petersen K, Luukkainen RK, Combe B, Burmester GR, Devlin J, Ferraccioli G, Morelli A, Hoekstra M, Majdan M, Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Tunc R, Dimic A, Bergman M, Toloza S, Pincus T; QUEST-RA Group. Naranjo A, et al. Arthritis Res Ther. 2008;10(2):R30. doi: 10.1186/ar2383. Epub 2008 Mar 6. Arthritis Res Ther. 2008. PMID: 18325087 Free PMC article.
233 results